About this review
Healthcare organizations evaluating language access encounter a wide range of claims about interpreter use, patient safety, and outcomes. This review summarizes what published research actually shows, and just as importantly, what it does not.
One thing should be clear up front: the studies below evaluate human interpretation and language barriers in general. None of them tested Efatha or AI interpretation. They describe the language-access problem: communication quality, access, and outcomes. They do not describe the clinical performance of any product.
The clearest signal: trained interpretation improves communication quality
A cross-sectional analysis of 57 Spanish-language pediatric emergency encounters documented 1,884 interpretation errors. Eighteen percent were judged to have potential clinical consequences. That proportion was lower with professional interpreters (12%) than with ad hoc interpreters (22%) or no interpreter at all (20%). Among professional interpreters, at least 100 hours of prior training was associated with fewer total errors and a smaller share of potentially consequential ones.
What this supports: trained professional interpretation is safer than relying on ad hoc or absent interpretation in the studied setting. What it does not support: a universal error rate across all care settings, languages, or technologies, or any product-performance claim.
Access to professional interpreters remains uneven
A national U.S. ambulatory-care analysis found that 29.5% of outpatient physicians reported regularly using professional interpreters when working with patients with limited English proficiency. Forty percent reported never using them. Solo and group practices reported lower regular use than other settings.
An important limitation: physician-reported practice is not the same as a measured percentage of individual encounters. The finding supports a narrower conclusion: professional interpreter use is not routine across U.S. ambulatory care.
The moments where communication matters most
The AHRQ hospital guide identifies medication reconciliation, discharge, informed consent, emergency care, and surgical care as high-risk, communication-sensitive processes. Its recommendations center on safety culture, identifying and reporting errors, monitoring outcomes, and addressing root causes.
The practical implication: language access should be treated as a patient-safety system, not only as a translation transaction.
Utilization differences are real, but context-dependent
A systematic review and meta-analysis spanning 49 studies found modestly higher odds of adult hospital readmission (OR 1.11) and emergency-department revisits (OR 1.07) among language-discordant populations. Notably, in the subgroup of four adult-readmission studies that verified interpretation services were actually provided, the readmission difference was not significant (OR 0.90; 95% CI 0.77–1.05). The authors concluded interpretation may mitigate language-discordance effects, without establishing a universal causal effect.
Individual hospitals can show striking associations. A 2024 single-center U.S. ICU cohort found professional interpreter use associated with 46% lower odds of ICU readmission, alongside ICU stays 0.87 days longer. Selection effects are plausible: clinicians may reach for interpreters more often with sicker or more complex patients.
A recent two-hospital Canadian emergency-department study found language barriers associated with mean stays of 406.9 versus 342.4 minutes, about 65 additional minutes, along with more investigations, hospitalizations, and return visits. Only 52.2% of patients identified as having a language barrier used any interpretation; most interpreted through a family member, and 5% used a professional service.
Together, these studies support a bounded conclusion: local language-access gaps can coincide with meaningful operational and utilization differences. They do not support universal causal claims or direct forecasts for every health system.
Where the evidence is mixed
A systematic review of 26 hospital-based studies reported that 13 of 16 mortality studies found no significant association with limited English proficiency. Length-of-stay findings were split: nine studies found no difference, four found longer stays, three found shorter stays, and one reported mixed results. Readmission differences concentrated in some chronic-condition populations rather than acute or procedural cohorts, and five studies evaluating complications or harm found no differences between language groups.
The authors pointed to heterogeneous populations, inconsistent definitions, and limited data. Anyone claiming the outcome evidence is settled, in either direction, is overstating it.
How to read this evidence
The strongest conclusion available is also the most actionable one: dependable language access and trained interpretation matter for communication quality and safety. Access remains uneven, and the moments AHRQ flags (medication, consent, discharge, emergency and surgical care) deserve particular attention.
Utilization and outcome findings should be read as associations shaped by local context, not universal effects. And independent studies of human interpretation describe the broader language-access problem. They say nothing about the clinical performance of Efatha or any AI interpretation product.
Qualified human interpreters remain important. Technology, including Efatha, is best positioned as one way to make dependable support easier to reach, evaluated by each organization against the needs and risk of each encounter.